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(MI),5 stroke,6 and acute or chronic heart fail‑
ure (HF).7‑15 Notably, the relationship between 
RDW and outcome in HF was found to be inde‑
pendent of hemoglobin (Hb), hematocrit, mean 
corpuscular volume, or mean corpuscular Hb 
concentrations.16,17
Since HF is a widely spread condition among 
patients aged 65 or more, characterized by high 
hospitalization and mortality rates even when 
receiving the best available treatment, there is 
a need for assessing prognostic  factors immedi‑
ately upon the first episodes of decompensation, 
INTRODUCTION Red blood cell distribution 
width (RDW) is a numerical measure of the vari‑
ability in the size of circulating erythrocytes. 
This parameter is routinely reported as part 
of the complete blood count, but its use is gen‑
erally restricted to narrowing the differential 
diagnosis of anemia and hematologic disorders.1
Recent studies have linked an elevated RDW 
with poor cardiovascular outcome in sever‑
al distinct populations2 such as patients with 
stable coronary artery disease,3 acute coro‑


















BACKGROUND Red blood cell distribution width (RDW) is a risk factor related to adverse outcome in patients 
with heart failure (HF). Less is known about its role in patients in their first hospitalization for HF.
AIMS Our objective was to investigate the prognostic role of RDW in elderly patients hospitalized for 
acute HF for the first time.
METHODS We reviewed all patients aged 65 years or older admitted to a tertiary-care university hospital 
with a main diagnosis of acute HF during a 2-year period (January 2013 to December 2014). Patients were 
divided into 2 groups according to admission RDW values (<15% or ≥15%).
RESULTS A total of 897 patients were included in the study. Mean (SD) age was 80.25 (7.6) years. Admission 
RDW was 15% or higher in 474 patients (52.8%), with a mean (SD) RDW of 15.5% (2.3%). Multivariable 
analysis confirmed the relationship between a higher RDW on admission and a previous diagnostic history 
of diabetes and higher serum sodium concentrations on admission. All -cause mortality was higher among 
patients with RDW of 15% or more at 1 year follow -up (29.6% vs 23.2%, P = 0.03). Multivariate analysis 
confirmed the association between RDW and higher risk of 1-year mortality, as well as with older age, 
higher Charlson comorbidity index, higher potassium serum concentrations, and no hypertension as 
a previous diagnosis.
CONCLUSIONS In elderly patients experiencing their first admission due to acute HF, a higher RDW 
at baseline might help identify those at higher risk for 1-year all -cause mortality.
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discharged directly home within 24 hours after 
emergency department admission or transferred 
to other acute care hospitals were also exclud‑
ed. All doubts regarding inclusion in the study 
were discussed by the investigators’ revision 
panel. The ethics committee of Bellvitge Uni‑
versity Hospital approved the overall protocol 
(PR2016/16).
Heart failure was clinically confirmed accord‑
ing to the Framingham criteria. Collected data 
included demographics, medical history, and 
all clinical information related to HF signs and 
symptoms recorded on admission. Moreover, we 
collected data on chronic therapies used by pa‑
tients on a long ‑term basis. In cases where echo‑
cardiographic data were available, we recorded 
ejection fraction (EF) values and we classified 
HF as preserved EF type when the EF value was 
50% or more. A complete blood cell count and 
basic blood chemistry panel were obtained, in‑
cluding renal function (plasma creatinine val‑
ues plus the estimated glomerular filtration rate 
calculated according to the abbreviated Modi‑
fication of Diet in Renal Disease equation),19 as 
well as ionic, lipid, and glycemic profiles. Unfor‑
tunately, the plasma concentration of  N‑termi‑
nal fragment of the prohormone brain natriuret‑
ic peptide (NT ‑proBNP) was not available at our 
hospital at the time of the study, so this param‑
eter could not be evaluated in a proportion of 
patients on admission, and it was excluded from 
the data collection procedures. Anemia was de‑
fined according to the World Health Organiza‑
tion criteria as a Hb value of less than 13 g/dl 
for men and of less than 12 g/dl for women. We 
also assessed the length of hospital stay, comor‑
bidity, and medications prescribed on discharge.
Procedure The study population was divided 
into 2 groups depending on the RDW cutoff val‑
ue of 15%, chosen on the basis of a recently pub‑
lished model for early risk stratification in pa‑
tients with acute HF. Patients with HF with an 
RDW of 15% or more had approximately 3‑fold 
higher odds of experiencing a new HF ‑related 
event during the 1‑year follow ‑up, compared 
with those with an RDW lower than 15%.16
Follow ‑up During the follow ‑up, only the 
data on the patients’ vital status were collect‑
ed. The main outcome of the present study was 
1‑year all ‑cause mortality, measured as time ‑to‑
‑event data after discharge. The 30‑day mortality 
rate was also measured as a secondary outcome. 
The mortality status was determined by trained 
physician adjudicators on the basis of medical 
records from hospitalizations, emergency room 
visits, death certificates, and autopsy and coro‑
ner’s reports, when available. No patients were 
lost to follow ‑up.
in order to promptly implement preventive and 
treatment measures in such population accord‑
ing with HF risk stratification.
The aim of our study was to investigate the val‑
ue of RDW as a predictor of 1‑year all ‑cause mor‑
tality in a previously nonevaluated population 
aged 65 or more in their first hospitalization for 
acute decompensated HF.
METHODS This retrospective study was per‑
formed at the Bellvitge University Hospital, 
a 750‑bed tertiary ‑care public hospital in Bar‑
celona, Spain. The study design was described 
previously.18 In brief, within a 24‑month pe‑
riod (January 2013 – December 2014), we re‑
trieved administrative data regarding all con‑
secutive patients aged 65 or more with HF as 
the main discharge diagnosis. We chose 65 
years as the cutoff age because most of the pa‑
tients admitted during that period where 65 
years of age or older, thus eliminating the small 
percentage of younger patients to create 
a more uniform study sample. We decided to 
focus on patients during their first hospital‑
ization to standardize the sample, and to put 
our attention to elderly HF patients because 
this issue has been poorly explored so far.18 
All medical records were reviewed in order 
to select only those patients who fulfilled clin‑
ical criteria for acute HF and were admitted for 
the first time. We excluded those who had been 
previously hospitalized with a primary or sec‑
ondary diagnosis of HF prior to the index ad‑
mission. We also excluded patients younger 
than 65 years and those who, besides experi‑
encing a first ‑ever acute HF admission, were 
also diagnosed with advanced comorbidity such 
as cancer, severe dementia (Global Deteriora‑
tion Scale, 6–7), or other organ ‑specific diseases 
(chronic obstructive pulmonary disease, chron‑
ic kidney disease, or liver diseases considered to 
have short life expentancy. Patients presenting 
with HF secondary to an acute coronary syn‑
drome, and those emergency patients who were 
WHAT’S NEW?
Red blood cell distribution width (RDW) is a numerical measure of the variability 
in the size of circulating erythrocytes and its use is generally restricted 
to narrowing the differential diagnosis of anemia and hematologic disorders. 
An elevated RDW has been reported to be associated with poor cardiovascular 
outcomes. Therefore, we attempted to investigate the value of RDW as a predictor 
of 1-year all -cause mortality in a population of patients aged 65 or older, who 
were previously not evaluated and were hospitalized for acute decompensated 
heart failure for the first time. We confirmed that after the 1-year follow -up, 
the mortality rate was higher in patients with an RDW of 15% or more 
as compared with those with an RDW of less than 15%. These results suggest 
that a simple laboratory measurement can be very useful in evaluating 
the prognosis of elderly patients admitted for the first time for acute heart 
failure.
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used in this logistic regression were those as‑
sociated in the bivariate analysis. The final ad‑
justed model was obtained using the backward 
stepwise method. We used the Cox regression 
model to evaluate the relationship (estimated 
as hazard ratios [HRs]) between the presence 
of an RDW of 15% or higher and all ‑cause mor‑
tality over time. Covariates used for the adjust‑
ment of baseline variables were also evaluated 
in a stepwise Cox multivariable regression anal‑
ysis, incorporating all of them with P value of 
less than 0.05 in the univariate analysis. Final‑
ly, Kaplan–Meier survival curves and the log‑
‑rank test as a function of patients’ RDW cate‑
gory were calculated from baseline to the time 
of censoring. These analyses were conducted 
with the SPSS program (version 21.0, SPSS Inc., 
Chicago, Illinois, United States). The tests were 
2‑sided and P values of less than 0.05 were con‑
sidered significant.
RESULTS A  total of 897 patients were in‑
cluded in the study; their mean (SD) age was 
80.25 (7.6) years and 507 (56.5%) of them were 
women. Echocardiography was available during 
the index admission for 377 patients (42%). Out of 
those, 42% had HF with preserved EF and the re‑
maining patients had reduced or intermediate EF. 
The mean (SD) Hb value was 11.9 (4.7) g/dl, and the 
mean (SD) RDW value was 15.5 (2.3). RDW was 
15% or higher in 474 patients (52.8%). Of them, 
204 were men (43%) and 270 were women (57%). 
A total of 126 patients (26.6%) had a previous di‑
agnosis of anemia before index admission, and 
330 (69.6%) fulfilled the World Health Organiza‑
tion criteria for anemia on admission.
Baseline differences between patients with 
an RDW of less than 15% and 15% or higher are 
reported in TABLE 1. Patients with an RDW of 15% 
or higher had a higher prevalence of diabetes, 
had been more often diagnosed with anemia, 
and showed a higher χ2 score. Furthermore, pa‑
tients with an RDW of 15% or higher were us‑
ing a higher number of chronic therapies at the 
time of the first hospitalization for acute HF. 
Regarding admission laboratory tests, patients 
with an RDW of 15% or higher presented higher 
creatinine concentrations, lower Hb values, and 
higher serum sodium concentrations on admis‑
sion. Finally,  these patients had a longer length 
of hospital stay during index admission.
The multivariate analysis confirmed a signifi‑
cant and independent relationship between the 
RDW of 15% or higher and a prior diagnosis of 
diabetes (OR, 1.48; 95% CI, 1.11–1.97) as well as 
higher serum sodium concentrations (OR, 1.05; 
95% CI, 1.02–1.08), but the association with Hb 
concentrations, creatinine value, a previous diag‑
nosis of anemia, and higher χ2 scores lost the as‑
sociation found in the baseline data comparison.
Statistical analysis Normally distributed con‑
tinuous variables were reported as mean (SD) 
and categorical variables as proportions. 
The t test was used to compare continuous vari‑
ables, with a previous Levene test for equality of 
variances, while either the χ2 test or Fisher ex‑
act test was used to compare categorical or di‑
chotomous variables. A logistic regression anal‑
ysis was performed to determine, at the mul‑
tivariate level, the baseline factors associated 
with the presence of an RDW of less than 15% 
or 15% or higher on admission. This procedure 
was used to estimate the unadjusted and ad‑
justed odds ratio (OR) with 95% CI. Variables 
TABLE 1 Baseline characteristics of patients hospitalized for acute heart failure 
for the first time, according to red blood cell distribution width on admission
Parameter RDW ≥15%
(n = 474; 52.8%)
RDW <15%
(n = 423; 47.2%)
P value
Age, y, mean (SD) 79.96 (7.7) 80.5 (7.5) 0.22
Sex, female, n (%) 270 (57) 237 (56) 0.83
HFpEF, n (%) (n = 377) 155 (69.8) 110 (71) 0.81
Charlson index, mean (SD) 2.44 (1.85) 2.04 (1.6) 0.001
Length of stay, days, median 
(range)
6 (4–10) 4 (3–7) 0.001
Chronic therapies, n, mean 
(SD)
8.9 (3.5) 8.1 (3.3) <0.001
Medical history, n (%)
Coronary artery disease 
(n = 213)
109 (23) 104 (24.6) 0.58
Dyslipidemia (n = 495) 271 (57.2) 224 (53) 0.23
Diabetes mellitus (n = 340) 202 (42.6) 138 (32.6) 0.003
Hypertension (n = 772) 418 (88.2) 354 (83.7) 0.05
COPD (n = 195) 92 (19.4) 103 (24.3) 0.07
CKD (n = 234) 131 (27.6) 103 (24.3) 0.26
Atrial fibrillation (n = 340) 185 (39) 155 (36.6) 0.51
Dementia (n = 37) 34 (7.2) 33 (7.8) 0.72
Known anemia (n = 185) 126 (26.6%) 59 (13.9%) <0.001
Laboratory tests
Hemoglobin, g/dl, mean (SD) 11.23 (2.0) 12.71 (6.4) <0.001









901 (169–1400) 900 (250–1500) 0.96
Creatinine, µmol/l, mean (SD) 124.5 (6528.2) 109.3 (60.6) 0.01
eGFR, ml/min, mean (SD) 57.9 (28.2) 61 (25.6) 0.08
Sodium, mmol/l, mean (SD) 138.7 (4.5) 138.1 (4.34) 0.04
Potassium, mmol/l, mean (SD) 4.2 (0.6) 4.2 (0.5) 0.89
Abbreviations: CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; eGFR, 
estimated glomerular filtration rate (Modification of Diet in Renal Disease equation); HFpEF, heart 
failure with preserved ejection fraction; RDW, red blood cell distribution width
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a common finding (52.8%) among elderly pa‑
tients at the first admission for acute HF, but 
also an independent predictor of a higher risk 
of 1‑year all ‑cause mortality.
An abnormal RDW has been previously re‑
ported to be a common finding in the overall 
population of patients with HF,20 although im‑
portant differences in its prevalence have been 
found, depending on the cutoff values used. 
Nonetheless, the prevalence reported in our 
study was slightly higher than that previously 
described by Allen et al,20 using a similar RDW 
cutoff value. In a cohort of 1016 ambulatory pa‑
tients from the STAMINA ‑HFP registry, 31% of 
patients had RDW higher than 15%. Percentag‑
es more similar to the ones showed in the pres‑
ent study were also reported by Bonaque et al10 
in a population of 698 consecutive outpatients 
with chronic HF (48%), who used a slightly low‑
er RDW cutoff of 14.8%. On the contrary, a sig‑
nificantly lower percentage of an altered RDW 
(18.5%) was reported by Cauthen et al21 in 6159 
consecutive ambulatory patients with chron‑
ic HF, using an RDW cutoff of 16%.
Our patient population with an RDW of 15% 
or higher more often showed a concomitant pre‑
vious diagnosis of diabetes when compared with 
patients with normal RDW. The significant re‑
lationship between RDW increase and coexist‑
ing diabetes found in our study has been also 
described in some recent studies, suggesting 
an interesting interaction between diabetic sta‑
tus and RDW.22,23 Furthermore, these patients 
also had higher sodium levels on admission. To 
our knowledge, although the detection of hy‑
pernatremia in such patients with HF seems to 
have an uncertain clinical significance, this as‑
sociation has never been previously described 
in literature.
Similarly, no investigations have been pub‑
lished to date reporting the other association 
found in our study between an abnormal RDW 
and higher plasma creatinine levels on admission. 
Although this association lost significance in the 
multivariate analysis in our elderly patients, re‑
cent reports have validated the role of RDW as 
a prognostic marker in patients with chronic kid‑
ney disease.24
Patients with an RDW of 15% or higher also had 
a higher number of long ‑term therapies prior to 
the index hospitalization, showed a higher num‑
ber of comorbidities, more often presented ane‑
mia prior to HF hospitalization, and had lower Hb 
levels and higher creatinine levels on admission 
than patients with an RDW of less than 15%. Fur‑
thermore, these patients showed a longer hospital 
stay during the index admission. However, none 
of the above conditions were found to be signifi‑
cant in the multivariate analysis.
Regarding prognosis, our results confirmed 
that the 1‑year mortality rate was higher among 
elderly patients with an RDW of 15% or higher 
All ‑cause mortality All ‑cause mortality was 
higher in patients with an RDW of 15% or high‑
er during the index admission (6.8 vs 3.8%, P = 
0.049), within the first 30 days after discharge 
(11.8% vs 7.1%, P = 0.02), and after 1 year follow‑
‑up (29.6% vs 23.2%, P = 0.03) (TABLE 2). Baseline 
and discharge data between patients alive and 
deceased after the 1‑year follow ‑up are compared 
in TABLE 3. The 1‑year survival curves for both RDW 
groups are shown in FIGURE 1. The multivariate anal‑
ysis confirmed that the presence of an RDW of 
15% or higher at the time of the first admission 
due to acute decompensated HF in patients aged 
65 or older was independently associated with 
a higher risk of 1‑year all ‑cause mortality (HR, 
1.41; 95% CI, 1.05–1.90). Other independent fac‑
tors associated with a higher 1‑year mortality 
risk were older age (HR, 1.08; 95% CI, 1.06–1.10), 
higher comorbidity measured by the χ2 (HR, 1.13; 
95% CI, 1.05–1.22), and higher blood potassium 
concentrations on admission (HR, 1.424; 95% 
CI, 1.12–1.81). Prior hypertension appeared to be 
an independent factor associated with a better 
prognosis (HR, 0.50; 95% CI, 0.34–0.70).
DISCUSSION Interestingly, our study showed 
that an abnormally increased RDW was not only 
TABLE 2 Thirty ‑day mortality and 1‑year all ‑cause mortality after the first 
hospitalization for acute heart failure, according to baseline red blood ‑cell 
distribution width value





In -hospital mortality 48 (5.4) 32 (6.8) 16 (3.8) 0.049
All -cause 30-day mortality 86 (9.6) 56 (11.8) 30 (7.1) 0.02
All -cause 1-year mortality 239 (26.6) 141 (29.7) 98 (23.2) 0.03
Data are shown as number (percentage) of patients.
Abbreviations: see TABLE 1

















FIGURE 1 Proof 
of equality of survival 
distributions for red blood 
cell distribution width of 15% 
or higher and less than 15%
KARDIOLOGIA POLSKA 2019; 77 (6)636
identified RDW as a novel independent mark‑
er of adverse outcome and mortality rates in 
chronic and acute HF.7 However, these studies 
mostly evaluated patients with chronic HF and 
a history of repeated episodes of HF decomposi‑
tion, for which RDW anomalies could be a mark‑
er of a more advanced disease. Interestingly, in 
our cohort of elderly patients admitted because 
of the first episode of acute decompensated HF, 
an RDW of 15% or higher predicted not only 
1‑year mortality but also in ‑hospital and 30‑day 
mortality after discharge.
Older age, a higher number of comorbidities 
measured by the χ2 test, and a higher blood po‑
tassium concentration documented on admis‑
sion were the other factors, in addition to RDW, 
independently associated with a higher risk of 
1‑year mortality in the multivariate analysis. 
Regarding plasma potassium concentrations in 
patients admitted for worsening HF, although 
hypokalemia is a common feature after aggres‑
sive diuresis, a considerable increase in serum 
potassium levels is also observed in elderly pa‑
tients with HF and impaired renal function or 
as an adverse effect related to some medications 
used in HF.25 Thus, because of its associated risk 
for life‑threatening arrhythmias and conduction 
system abnormalities, the potential role of hy‑
perkalemia in predicting mortality in our study 
population is not surprising.26
Previous data showing the role of abnormal 
RDW as a predictor of readmissions or prog‑
nostic factor for all ‑cause mortality have been 
mainly reported in patients with chronic HF in 
the outpatient setting.10 Some of these studies 
found RDW and NT ‑proBNP to be independent 
predictors of adverse clinical events in chronic 
HF.11 RDW showed a similar prognostic power 
for predicting all ‑cause mortality to that of NT‑
‑proBNP in a study by Al ‑Najjar et al12 in a popu‑
lation of 1087 ambulatory patients with HF with 
reduced ejection fraction. Moreover, in a cohort 
of 205 patients with acute HF, von Kimmenade 
et al13 reaffirmed the clinical value of RDW as a 
predictor of 1‑year mortality in addition to oth‑
er well ‑established prognostic markers such as 
NT ‑proBNP.
Concerning the specific group of patients ad‑
mitted due to HF for the first time, some previ‑
ous scattered studies already highlighted a high‑
er prevalence of increased RDW in such pop‑
ulation.8 Furthermore, Makhoul et al9 found 
that an abnormal RDW is a strong independent 
predictor of higher morbidity and mortality, as 
much as an increase in RDW during hospital‑
ization also portends a worse clinical outcome.
On the other hand, a higher prevalence of 
anemia among HF patients with a higher RDW 
is a well ‑reported association in literature. Al‑
though anemia is also a well ‑known prognostic 
factor for predicting mortality in HF,18 RDW gen‑
erally appears to be an independent prognostic 
compared with the other subgroup (29.6% vs 
23.2%, P = 0.03). Similarly to other cardiovas‑
cular diseases, some previous studies have 
TABLE 3 Clinical differences between patients deceased and alive after 1 year of 
follow ‑up after the first hospitalization for acute heart failure
Parameter Mortality P value
Yes (n = 239; 26.6%) No (n = 658; 73.4%)
Age, y, mean (SD) 83.4 (7.89) 79.11 (7.2) <0.001
Sex, female, n (%) 141 (59) 366 (55.6) 0.37
HFpEF, n (%) (n = 377) 51 (63.8) 214 (72) 0.15
Charlson index, mean (SD) 2.6 (1.99) 2.12 (1.66) 0.001
Length of stay, d, 
median (range)
5 (3–8) 6 (4–11) 0.001
Chronic therapies, n, 
mean (SD)
8.6 (3.5) 8.5 (3.45) 0.77
Medical history, n (%)
Coronary artery disease 52 (21.8) 161 (24.5) 0.4
Dyslipidemia 122 (51) 373 (56.7) 0.13
Diabetes mellitus 82 (34.3) 258 (39.2) 0.18
Hypertension 190 (79.5) 582 (88.4) 0.001
COPD 57 (23.8) 138 (21) 0.36
CKD 71 (29.7) 163 (24.8) 0.14
Atrial fibrillation 86 (36) 254 (38.6) 0.48
Dementia 26 (10.9) 41 (6.2) 0.02




11.29 (2.13) 12.16 (5.37) 0.02










1000 (170–1500) 900 (275–1300) 0.07
Creatinine, µmol/l, 
mean (SD)
124.5 (65.6) 111.5 (61) 0.01
eGFR, ml/min, mean (SD) 55.5 (29.7) 60.8 (25.9) 0.01
Sodium, mmol/l, mean (SD) 137.98 (5.18) 138.6 (4.17) 0.11
Potassium, mmol/l, 
mean (SD)
4.4 (0.64) 4.2 (0.54) <0.001
Medication at discharge, n (%)
ACEIs / ARBs 101 (52.9) 430 (65.3) 0.002
β ‑Blockers 83 (43.5) 356 (54.1) 0.01
MRAs 22 (11.5) 77 (11.7) 0.94
Loop diuretics 181 (94.8) 629 (95.6) 0.63
Thiazide 8 (4.2) 45 (6.8) 0.18
Abbreviations: ACEI, angiotensin -converting enzyme inhibitor; ARB, angiotensin receptor blocker; 
CKD, chronic kidney disease; HFpEF, heart failure with preserved ejection fraction; MRA, 
mineralocorticoid receptor antagonist; others, see TABLE 1
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that there were no dropouts during the 1‑year 
follow ‑up.
In conclusion, an RDW value of 15% or high‑
er was present on admission in more than 
half of our elderly patients firstly hospitalized 
due to acute HF. Importantly, when compared 
with the group of patients with normal RDW, 
those with an RDW of 15% or higher showed 
higher all ‑cause mortality rates, either during 
the index admission, or within the first 30 days 
and 1 year after discharge. The RDW value of 15% 
or or higher on admission might help identify 
patients at higher risk for 1‑year all ‑cause mor‑
tality. Whether a direct pathogenic mechanism 
explains this association (RDW anomalies and 
higher risk of mortality in the elderly HF popula‑
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factor beyond its clinical association with oth‑
er hematologic laboratory parameters such as 
Hb or mean corpuscular volume.17 This indepen‑
dent prognostic role of RDW was confirmed in 
a study conducted over a 2‑year period in a co‑
hort of 628 consecutive patients hospitalized 
for acute HF, for whom higher RDW levels were 
associated with a worse long ‑term outcome af‑
ter discharge, regardless of Hb levels and ane‑
mia status.26
The  analysis of data collected from the 
CHARM (Candesartan in Heart Failure: Assess‑
ment of Reduction in Mortality and Morbidity) 
Program and the Duke Databank suggested that 
RDW has higher statistical association with poor 
outcome than other widely accepted risk factors 
such as ejection fraction, New York Heart Asso‑
ciation functional class, or renal function.14 Of 
note, RDW has been recently included as a deter‑
minant for an early risk stratification of the HF 
population, showing that patients with an RDW 
of 15% or higher had approximately 3‑fold high‑
er odds of experiencing a HF ‑related episode of 
readmission or death, during a 1‑year follow ‑up, 
when compared with those with a lower RDW 
value.16 However, the specific mechanistic links 
between RDW and poor prognosis in cardiovas‑
cular disease and HF have not yet been fully un‑
derstood, although it has been proposed that a 
higher RDW might be a consequence of the im‑
paired erythrocyte maturation secondary to 
the overall deleterious effects of the underly‑
ing HF ‑related inflammatory state.15
Our study has some limitations. It was a ret‑
rospective analysis and data were collected from 
electronic medical records. Data on NT ‑proBNP, 
iron status, or anemia ‑related blood parame‑
ters were scarce, and only a half of the popula‑
tion had an echocardiography performed during 
the index admission. Data on antiplatelet and 
anticoagulant drug use were not collected. A re‑
cent study reported that RDW increases in HF 
within 96 hours of hospitalization; nevertheless, 
we did not collect data regarding RDW dynamic 
changes during hospitalization.27 Another limi‑
tation is the lack of control blood tests, neither 
at the first month nor after the 1‑year follow‑
‑up. Although it has been reported that an ele‑
vated RDW was associated with poorer LV de‑
formation assessed by speckle tracking echocar‑
diography in HF patients with similar ejection 
fraction, we were unable to assess this.28 Final‑
ly, the study did not include the possible pre‑
cipitating factors. Actually, for many patients 
the first hospitalization coincided with the di‑
agnosis of the disease. 
On the other hand, we would like to high‑
light some of the strengths of the study, such as 
the relatively high number of patients, all care‑
fully selected as presenting with their first ‑time 
ever clinical episode of acute HF (confirmed by 
an accurate medical record review), and the fact 
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